Search results
Showing 376 to 390 of 405 results for stroke
Biggest shake-up in type 2 diabetes care in a decade announced
Millions of people are set to benefit from earlier access to newer type 2 diabetes treatments – the biggest shake-up in care for a decade – as part of NICE’s commitment to re-evaluate priority clinical pathways described in the 10-Year Health Plan for the NHS.
Recommendations in NICE’s type 2 diabetes guideline update, published today, will enhance the use of SGLT-2 inhibitors in primary care and address these health inequalities.
Jamaican café, where he eats his main meal of the day. However since having a stroke he lacks the confidence to leave the house. His...
Hypertension case finding and optimal management and lipid optimal management
infarction and stroke. To allow for interventions to optimise blood pressure and minimise the risk of myocardial infarction and...
Jamaican café, where he eats his main meal of the day. However since having a stroke Adio lacks the confidence to leave the house....
Jamaican café, where he eats his main meal of the day. However since having a stroke he lacks the confidence to leave the house. His...
We've mapped relevant NICE guidance and advice to NHS England’s Core20PLUS5 for adults
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
The innovative hybrid closed loop (HCL) systems offer improved blood sugar control and can transform daily life for families managing this complex condition.
Dr Sarah Byron discusses how NICE is transforming to ensure more digital health technologies are adopted by the NHS.
Annual BMI checks recommended for adults with long-term conditions
We've published a draft quality standard calling for yearly BMI and waist-to-height measurements to help prevent weight-related complications.
Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits for patients
NICE describes how weight loss drug tirzepatide will be rolled out
The medication will initially be offered only to those people with the highest clinical needs.
Home testing devices could increase the number of people diagnosed with sleep apnoea
Five home-testing devices to diagnose a silent sleep condition harming the health of an estimated 2.5 million adults have been recommended by NICE in draft guidance.
NICE has approved mavacamten, the first treatment that specifically targets a heart condition called obstructive hypertrophic cardiomyopathy (HCM). It means around 7,000 people will now be able to access the treatment on the NHS.